Immunoexpression of IgA receptors (CD89, CD71) in dermatitis herpetiformis
Abstract
Introduction. The role of IgA receptors in dermatitis herpetiformis (DH) pathogenesis is still unknown. CD89 and CD71 may be associated with immune response during DH development. The purpose of this study was to perform semiquantitative analysis of simultaneous immunoexpression of CD89 and CD71 in DH and IgA/neutrophil-mediated non-DH dermatoses (IgAN) in relation to specific IgA autoantibodies/antibodies (tissue and epidermal transglutaminases, nonapeptides of gliadin — eTG/tTG/npG) as well neutrophil activation via the release of neutrophil elastase (NE).
Material and methods. In total, 48 patients were studied. The study was conducted on skin lesions and sera obtained from DH and IgAN patients. DH and IgAN served as mutually positive control groups. We used immunohistochemical technique with semiquantitative digital morphometry and ELISA to measure serum levels of anti-eTG/tTG/npG IgA.
Results. CD89 showed a significantly higher expression in DH than in IgAN. CD71 was overexpressed in DH and IgAN. CD89 immunoexpression correlated negatively with CD71 in IgAN. A positive correlation was revealed between CD89 immunoexpression and anti-npG IgA in DH. No statistically significant correlations were found in DH between the CD89/CD71 and NE immunoexpression, between CD71 immunoexpression and anti-tTG/eTG/npG IgA, or between CD89 immunoexpression and anti-eTG/tTG IgA serum levels.
Conclusions. CD89 is probably a key IgA Fc receptor in DH development, where it is associated with immune response to gluten. CD71 may be linked with inflammation in DH and IgAN. We suggest that interaction between CD89 and CD71 can modulate the inflammation in IgAN.
Keywords: dermatitis herpetiformisIgANFc-alpha receptorCD71CD89IHC
References
- Gornowicz-Porowska J, Bowszyc-Dmochowska M, Seraszek-Jaros A, et al. Cutaneous expressions of interleukin-6 and neutrophil elastase as well as levels of serum IgA antibodies to gliadin nonapeptides, tissue transglutaminase and epidermal transglutaminase: implications for both autoimmunity and autoinflammation involvement in dermatitis herpetiformis. Cent Eur J Immunol. 2014; 39(3): 331–337.
- Gornowicz-Porowska J, Bowszyc-Dmochowska M, Dmochowski M. Autoimmunity-driven enzymatic remodeling of the dermal-epidermal junction in bullous pemphigoid and dermatitis herpetiformis. Autoimmunity. 2012; 45(1): 71–80.
- Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol. 1996; 132(8): 912–918.
- Kotze LM. Dermatitis herpetiformis, the celiac disease of the skin! Arq Gastroenterol. 2013; 50(3): 231–235.
- Volta U, Molinaro N, De Franchis R, et al. Correlation between IgA antiendomysial antibodies and subtotal villous atrophy in dermatitis herpetiformis. J Clin Gastroenterol. 1992; 14(4): 298–301.
- Hendrix JD, Mangum KL, Zone JJ, et al. Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol. 1990; 94(5): 667–672.
- Smith AD, Streilein RD, Hall RP. Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis. Br J Dermatol. 2002; 147(6): 1109–1117.
- Gomes MM, Herr AB. IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential. Springer Semin Immunopathol. 2006; 28(4): 383–395.
- Moresco RN, Speeckaert MM, Zmonarski SC, et al. Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and henoch-Schönlein purpura nephritis. BBA Clin. 2016; 5: 79–84.
- Wehrli M, Cortinas-Elizondo F, Hlushchuk R, et al. Human IgA Fc Receptor FcαRI (CD89) Triggers Different Forms of Neutrophil Death Depending on the Inflammatory Microenvironment. J Immunol. 2014; 193(11): 5649–5659.
- Ben Mkaddem S, Rossato E, Heming N, et al. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives. Autoimmun Rev. 2013; 12(6): 666–669.
- Daniels TR, Delgado T, Rodriguez JA, et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol. 2006; 121(2): 144–158.
- Wiwanitkit V. IgA-CD89 complex in IgA nephropathy: a study on molecular function. Ren Fail. 2006; 28(6): 457–459.
- Maneva A, Taleva B. Receptors for transferrin on human neutrophils. Biotechnol & Biotechnol Eq. 2009; 23: 477–479.
- Monteiro RC. Role of IgA and IgA fc receptors in inflammation. J Clin Immunol. 2010; 30(1): 1–9.
- Bairoch A, Apweiler R, Wu CH, et al. The Universal Protein Resource (UniProt). Nucleic Acids Res. 2005; 33(Database issue): D154–D159.
- Berthelot L, Papista C, Maciel TT, et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med. 2012; 209(4): 793–806.
- Gornowicz-Porowska J, Bowszyc-Dmochowska M, Seraszek-Jaros A, et al. Association between levels of IgA antibodies to tissue transglutaminase and gliadin-related nonapeptides in dermatitis herpetiformis. ScientificWorldJournal. 2012; 2012: 363296.
- Gornowicz-Porowska J, Seraszek-Jaros A, Kaczmarek E, et al. IgA autoantibodies to gliadin nonapeptides, tissue transglutaminase and epidermal transglutaminase are associated, but unrelated to neutrophil elastase expression in lesional skin in human dermatitis herpetiformis. Postępy Dermatol Alergol. 2012; 4: 233–239.
- Gornowicz-Porowska J. Expression of neutrophil elastase in relation to the autoimmunity to epidermal transglutaminase, BP180, BP230, desmoglein 1 and 3 in autoimmune blistering dermatoses. Saarbrücken, Germany: LAP Lambert Academic Publishing GmbH&Co Kg. ; 2012.
- Gornowicz-Porowska J, Seraszek-Jaros A, Bowszyc-Dmochowska M, et al. A comparative study of expression of Fc receptors in relation to the autoantibody-mediated immune response and neutrophil elastase expression in autoimmune blistering dermatoses. Pol J Pathol. 2017; 68(2): 109–116.
- Kasprzak A, Szmyt M, Malkowski W, et al. Analysis of immunohistochemical expression of proinflammatory cytokines (IL-1α, IL-6, and TNF-α) in gallbladder mucosa: comparative study in acute and chronic calculous cholecystitis. Folia Morphol (Warsz). 2015; 74(1): 65–72.
- Kasprzak A, Rogacki K, Adamek A, et al. Tissue expression of β-catenin and E- and N-cadherins in chronic hepatitis C and hepatocellular carcinoma. Arch Med Sci. 2017; 13(6): 1269–1280.
- Bakema JE, van Egmond M. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity. Mucosal Immunol. 2011; 4(6): 612–624.
- Hall RP, Takeuchi F, Benbenisty KM, et al. Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha. J Invest Dermatol. 2006; 126(6): 1331–1337.
- Müllner EW, Kühn LC. A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell. 1988; 53(5): 815–825.
- Marsee DK, Pinkus GS, Yu H. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol. 2010; 134(3): 429–435.
- Magro G, Cataldo I, Amico P, et al. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. Thyroid. 2011; 21(3): 267–277.
- Korneychuk N, Meresse B, Cerf-Bensussan N. Lessons from rodent models in celiac disease. Mucosal Immunol. 2015; 8(1): 18–28.
- Heyman M, Menard S. Pathways of gliadin transport in celiac disease. Ann N Y Acad Sci. 2009; 1165: 274–278.
- Wijarnpreecha K, Thongprayoon C, Panjawatanan P, et al. Celiac disease and the risk of kidney diseases: A systematic review and meta-analysis. Dig Liver Dis. 2016; 48(12): 1418–1424.
- Lebreton C, Ménard S, Abed J, et al. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology. 2012; 143(3): 698–707.e4.
